S. Farmer

Ganeden Biotech (United States)

Health Outcomes Studied

• Increased Beneficial Organic Acid Levels
• Increased Faecalibacterium prausnitzii Levels

Papers (9)

• 2019
  Spores of Bacillus coagulans GBI-30, 6086 show high germination, survival and enzyme activity in a dynamic, computer-controlled in vitro model of the gastrointestinal tract.10.3920/BM2018.0037
• 2017
  Bacillus coagulans GBI-30, 6086 increases plant protein digestion in a dynamic, computer-controlled in vitro model of the small intestine (TIM-1).10.3920/BM2016.0196
• 2017
  Probiotic Bacillus coagulans GBI-30, 6086 Improves Protein Absorption and Utilization10.1007/s12602-017-9354-y
• 2015
  Bacillus coagulans GBI-30, 6086 Modulates Faecalibacterium prausnitzii in Older Men and Women.10.3945/jn.114.199802
• 2014
  Effect of prebiotics on the fecal microbiota of elderly volunteers after dietary supplementation of Bacillus coagulans GBI-30, 6086.10.1016/j.anaerobe.2014.09.002
• 2012
  Probiotic metabolites from Bacillus coagulans GanedenBC30™ support maturation of antigen-presenting cells in vitro.10.3748/wjg.v18.i16.1875
• 2012
  Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-Induced colitis following vancomycin withdrawal in mice10.1186/1757-4749-4-13
• 2011
  Use of a continuous culture fermentation system to investigate the effect of GanedenBC30 (Bacillus coagulans GBI-30, 6086) supplementation on pathogen survival in the human gut microbiota.10.1016/j.anaerobe.2010.12.006
• 2010
  Survival and metabolic activity of the GanedenBC30 strain of Bacillus coagulans in a dynamic in vitro model of the stomach and small intestine.10.3920/BM2009.0009